logo
episode-header-image
Aug 2024
25m 18s

The human strain: can mpox be contained?

The Economist
About this episode

Mpox is spreading fast across Africa, yet public information campaigns are scant and vaccines in short supply. Is a new pandemic in the offing? Strategists are pondering a new potential threat from Russia: the possibility that it could detonate a nuclear weapon in space (09:42). And an Economist correspondent answers another of your questions about Artificial Intelligence (18:16). 


Listen to what matters most, from global politics and business to science and technology—Subscribe to Economist Podcasts+


For more information about how to access Economist Podcasts+, please visit our FAQs page or watch our video explaining how to link your account. 




Hosted on Acast. See acast.com/privacy for more information.

Up next
Yesterday
Liberté, égalité, désordre: chaos in France
France’s newly-appointed prime minister has resigned only weeks into the job. Now President Emmanual Macron has given him 48 hours to come up with a plan for next year’s budget. Can Macron survive the turmoil? As driverless taxis take over San Francisco, what will happen to the h ... Show More
21m 3s
Oct 7
Man of steel, and aluminium: Carney talks trade with Trump
The swiftest way for Prime Minister Mark Carney to ease pressure on Canada’s economy is to convince President Donald Trump today to pare back tariffs. But he has far broader plans afoot, too. A heady online mix of e-commerce and entertainment is creating a new generation of shopp ... Show More
21m 58s
Oct 6
One peace at a time: hopeful Gaza talks
As negotiators gather in Egypt, appetite for a short-term peace seems high on all sides. But there is much ambiguity surrounding a lasting accord. In New York, renters fear being evicted far less than they once did—but pity flat-hunters. And remembering Kim Seong Min, a North Kor ... Show More
22m 54s
Recommended Episodes
Aug 2024
The human strain: can mpox be contained?
Mpox is spreading fast across Africa, yet public information campaigns are scant and vaccines in short supply. Is a new pandemic in the offing? Strategists are pondering a new potential threat from Russia: the possibility that it could detonate a nuclear weapon in space (09:42). ... Show More
25m 18s
Feb 2025
War hoarse: is Zelensky being heard?
In an interview with The Economist ahead of the Munich Security Conference, Ukraine’s president is pessimistic that Trump can end the conflict. How fish farming in West Africa could improve food security (11.57). And contemplating the holy hashtags of FaithTok (17:10).  Listen to ... Show More
23m 21s
Sep 2
Call the shots: vaccine cuts imperil global health
America’s health secretary, RFK Jr, is known for his opposition to vaccines, particularly mRNA jabs, that have the potential to treat a large swathe of diseases. Slashing funding will have long term implications beyond America. Our correspondent visits Britain’s biggest and newes ... Show More
21m 26s
Aug 18
Peace by piece? Zelensky and Trump meet again
After an inconclusive summit between Donald Trump and Vladimir Putin in Alaska on Friday, the stakes are high for Volodymyr Zelensky’s meeting with the US president in Washington today. Enter the “solopreneur”: why AI is allowing entrepreneurs to start and grow businesses on thei ... Show More
21m 6s
Aug 2024
Electric eye: AI is helping fight terrorists
Predicting political violence is a painstaking job. Now AI is helping analysts look for clues and throwing up fascinating insights into the shifts that may indicate a strike is coming. Why Cuba could be heading towards economic and social collapse (11:01). And our correspondent v ... Show More
26m 19s
Sep 26
Under different thumbs: a scant TikTok deal
President Donald Trump’s executive order ostensibly puts a years-long debate to bed. But questions persist about who will own—and influence—TikTok’s American operations. We examine the evidence on how climate change will aid the spread of dengue fever, a brutal and potentially de ... Show More
23m 10s
Aug 21
Stake and chips: will America take 10% of Intel?
Intel was once synonymous with chip-making, but in recent years it has fallen behind. Now the Trump administration may become its biggest shareholder. A political assassination in Colombia raises fears about a return to violence. And what an annual snail race tells us about rural ... Show More
21m 2s
Sep 18
Wary pharma: AstraZeneca sours on UK
Pharmaceutical giant AstraZeneca has paused a £200m investment in Britain and could move its primary listing to America. Can the UK maintain its status as a “life-science superpower”? Why autonomous air wings are the future of war in the sky. And how scientists in the Caribbean a ... Show More
22m 31s
Sep 29
Fortunes of war: is Russia’s economy slowing?
The collapse of Russia’s wartime economy has long been foretold, yet massive fiscal stimulus has compensated for the effect of sanctions. Though the pinch is now being felt, the labour market is surprisingly resilient. Protesters in China are getting more creative. And why car to ... Show More
23m 30s
Sep 4
Mission possible: Baghdad is booming
Our correspondent meets Iraq’s prime minister Muhammad al-Sudani to discuss the country’s construction boom, its future aspirations and the obstacles that must still be overcome. Visit America’s YIMBYiest neighbourhood: the place where Americans actually want to increase the loca ... Show More
24m 46s